Affiliation(s)
1. Division of Total Quality Management and Institutional Development, Directorate of Public Health. Ministry of Health, Baghdad 10047, Republic of Iraq
2. Training and Development Division, Baghdad Al-rusafa directorate, Republic of Iraq
ABSTRACT
Hepatitis C&B
still the major problem in hemodialysis patients and the challenge continues in
dialysis centers to prevent spread among patients and workers, the worldwide
reported incidence of anti-HC antibody in dialysis center was range from 10.5%
-24% yearly and the prevalence range 5-85%. Also, HBs-antigen had the same
problem but with less incidence and prevalence. For the purpose of evaluating
the seroprevalence and seroconversion of anti-HC antibody and HBs-antigen in Haemodialysis centers at Baghdad
required action a retrospective incidence study from Nov. 2015 to Jan. 2016 on
maintenance HD patients at hemodialysis centers in Al-kindi, Al-Karama and
Baghdad Hospitals. The data obtained from patients records of
hospitals and we relied on laboratory test results for ELISA to determine the
seroconversion and seroprevalence of anti-HC-antibody and HBs-Antigen. The study found the total prevalence of
seropositive anti-HCV antibody in three centers were 251(28%), the seropositive
patients of HBs-Ag were 14(2%) While the total seroconversion was 196 (21%) anti-HCV antibody and for HBs-Ag 4 (0.4%); so there was serious risk of nosocomial infection
particularly for hepatitis C in the hemodialysis centers in Baghdad and
AL-kindi while the problem with HBV was under control at same time The
differences of seroconversion and seroprevalence of anti-HC antibody and HBs-antigen between the hospitals in the study may
indicate to the level of infection control was applied in hospital.
KEYWORDS
Seroconversion, seroprevalence, hemodialysis, hepatitis.
Cite this paper
References